John L. Higgins
2019
Compensation breakdown
| Non-Equity Incentive Plan | $291,686 |
|---|---|
| Option Awards | $2,891,109 |
| Salary | $648,192 |
| Stock Awards | $2,933,389 |
| Other | $6,000 |
| Total | $6,770,376 |
Higgins received $2.9M in stock awards, accounting for 43% of the total pay in 2019.
Higgins also received $291.7K in non-equity incentive plan, $2.9M in option awards, $648.2K in salary and $6K in other compensation.
Rankings
In 2019, John L. Higgins' compensation ranked 1,443rd out of 13,971 executives tracked by ExecPay. In other words, Higgins earned more than 89.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,443 out of 13,971 | 90th |
Division Manufacturing | 511 out of 5,695 | 91st |
Major group Chemicals And Allied Products | 155 out of 2,194 | 93rd |
Industry group Drugs | 123 out of 1,880 | 94th |
Industry Pharmaceutical Preparations | 93 out of 1,392 | 93rd |
Pay ratio
| John L. Higgins' Pay | $6,770,376 |
|---|---|
| Median Employee's Pay | $109,795 |
| Pay Ratio | 62to 1 |
In 2019, the annual total compensation of John L. Higgins was $6,770,376.
The annual total compensation of the median employee at Ligand Pharmaceuticals was $109,795.
The ratio of John L. Higgins' pay to the pay of median employee was therefore 62 to one.
Higgins' colleagues
We found three more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2019.